Gemtuzumab and hyperbilirubinaemia Patient Reports February 13, 2012

Gemtuzumab Side Effects Report #5028040-2
Gemtuzumab side effect was reported by a Consumer or non-health professional from POLAND on May 30, 2006. Female patient, 23 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, hepatomegaly, hyperbilirubinaemia, pneumonia , prothrombin level increased, pseudomonal sepsis, white blood cell count decreased. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CANCIDAS, FENTANYL, AMIKIN. Patient recovered.

Gemtuzumab Side Effects Report #5035412-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from POLAND on June 09, 2006. Female patient, 23 years of age, was diagnosed with myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: atelectasis, condition aggravated, fibrin d dimer increased, haemoglobin decreased, hepatomegaly, hyperbilirubinaemia, platelet count decreased, pneumonia , pseudomonal sepsis. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CANCIDAS, FENTANYL TRANSDERMAL SYSTEM, AMIKIN. Patient recovered.

Gemtuzumab Side Effects Report #5096653-8
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Aug 21, 2006. Male patient was diagnosed with juvenile chronic myelomonocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: anaphylactic shock, haematotoxicity, hyperbilirubinaemia, juvenile chronic myelomonocytic leukaemia, malignant neoplasm progression, transaminases increased. Gemtuzumab dosage: A SINGLE DOSE, 9 MG/M^2. Patient recovered.

Gemtuzumab Side Effects Report #5429701-3
Gemtuzumab side effect was reported by a Physician from BELGIUM on Aug 22, 2007. Male patient, 72 years of age, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, fluid retention, hyperbilirubinaemia, pancytopenia, shock haemorrhagic, venoocclusive disease. Gemtuzumab dosage: 11.6 MG. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died on 03/21/2005.


Gemtuzumab Side Effects Report #5434258-7
Gemtuzumab side effect was reported by a Physician from BELGIUM on Aug 28, 2007. Male patient, 72 years of age, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, fluid retention, hyperbilirubinaemia, pancytopenia, shock haemorrhagic, venoocclusive liver disease. Gemtuzumab dosage: 11.6 MG. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died on 03/21/2005.

Gemtuzumab Side Effects Report #4688359-1
Gemtuzumab side effect was reported by a Consumer or non-health professional from on June 01, 2005. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: ascites, bronchopulmonary aspergillosis, fluid retention, hepatic congestion, hepatic steatosis, hepatomegaly, hepatotoxicity, hyperbilirubinaemia, lung disorder. Gemtuzumab dosage: 11.6 MG. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #6039217-1
Gemtuzumab side effect was reported by a Physician from SPAIN on Jan 13, 2009. Male patient, 35 years of age, weighting 174.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: ascites, bacteraemia, haematotoxicity, hyperbilirubinaemia, hypovolaemic shock, ischaemic hepatitis, neutropenic colitis, oedema, pneumonia . Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, IDARUBICIN. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #6042039-9
Gemtuzumab side effect was reported by a Physician from SPAIN on Jan 13, 2009. Male patient, 35 years of age, weighting 174.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: ascites, bacteraemia, haematotoxicity, hyperbilirubinaemia, hypovolaemic shock, ischaemic hepatitis, neutropenic colitis, oedema, pneumonia . Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, IDARUBICIN. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #6057696-0
Gemtuzumab side effect was reported by a Physician from SPAIN on Jan 27, 2009. Male patient, 35 years of age, weighting 174.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: ascites, bacteraemia, haematotoxicity, hepatotoxicity, hyperbilirubinaemia, hypotension, hypovolaemic shock, ischaemic hepatitis, neutropenic colitis. Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, IDARUBICIN. Patient was hospitalized and became disabled. Patient recovered.


Gemtuzumab Side Effects Report #5291103-0
Gemtuzumab side effect was reported by a Physician from BELGIUM on Apr 04, 2007. Male patient, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, fluid retention, hyperbilirubinaemia, pancytopenia, shock haemorrhagic. Gemtuzumab dosage: 11.6 MG. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died on 03/21/2005.

Gemtuzumab Side Effects Report #5292219-5
Gemtuzumab side effect was reported by a Physician from BELGIUM on Apr 04, 2007. Male patient, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, fluid retention, hyperbilirubinaemia, pancytopenia, shock haemorrhagic. Gemtuzumab dosage: 11.6 MG. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died on 03/21/2005.

Gemtuzumab Side Effects Report #4631147-2
Gemtuzumab side effect was reported by a Pharmacist from on Apr 07, 2005. Male patient, child 10 years of age, weighting 143.3 lb, was diagnosed with acute lymphocytic leukaemia, leukaemia recurrent and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: ascites, fluid overload, hyperbilirubinaemia, hypotension, sepsis , transaminases increased, venoocclusive liver disease. Gemtuzumab dosage: 7.8 MG X 1 DOSE INTRAVENOU. During the same period patient was treated with ALEMTUZUMAB, MEROPENEM, VANCOMYCIN, METHYLPREDNISOLONE, PENTAMIDINE, AMBISOME, PROZAC. Patient recovered.